OncLive | Bringing the Global Oncology Community Together

A Type II variation application has been submitted to the European Medicines Agency for the combination of daratumumab with lenalidomide and dexamethasone for the treatment of patients with newly diagnosed multiple myeloma... Read More >>

NCCN 2019: Expert Addresses Therapeutic Updates for Breast Cancer Subtypes

NCCN 2019: Germline Testing Emphasized in NCCN Guidelines on Pancreatic Cancer

NCCN 2019: Frontline Combos Poised to Change NCCN Guidelines in Advanced RCC

BCMA Antibody-Drug Conjugate Continues to Extend PFS in Relapsed/Refractory Myeloma

Key Trials Seek to Expand on Efficacy, Tolerability of Treatment Regimens in Refractory CRC

View More Stories >>

View Conference Coverage

2019 NCCN Annual Conference

2019 State of the Science Summit on Hematologic Malignancies

2019 SGO Annual Meeting

2019 AACR Annual Meeting

2019 Miami Breast Cancer Conference

Dr. Nabors on Evolving Treatment Options for Brain Metastases

Dr. Pegram on Promising Novel Agents in HER2+ Metastatic Breast Cancer

Dr. Sznol on Unanswered Questions With Immunotherapy in RCC

Dr. Saettele on the Benefits of Using Bronchoscopies in NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

When to Use Inotuzumab Ozogamicin for Adult ALL

$Selecting a Novel Therapy for Relapsed/Refractory ALL$

Selecting a Novel Therapy for Relapsed/Refractory ALL

Allogeneic Transplant at First Remission of ALL

Establishing MRD's Role in ALL Management

Adjuvant Therapy for Early-Stage Colon Cancer

$Relapsed/Refractory mCRC: Treatment Dosing Strategies$

Choosing Therapy for Newly Diagnosed NonDriver NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Waldenstrom Macroglobulinemia: Diagnostic Criteria

Waldenstrom Macroglobulinemia: Risk Factors

$Relapsed/Refractory Multiple Myeloma: Switching Therapy$

Relapsed/Refractory Multiple Myeloma: Switching Therapy

$Relapsed/Refractory Multiple Myeloma: Optimal Therapy$

The Future of Pancreatic Cancer Treatment

BTK Inhibitors Explored in B-Cell Malignancies

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>